Article & News

Drug resistance is outpacing industrywide efforts, says Netherlandsbased Access to Medicine Foundation in its latest Antimicrobial Resistance (AMR) Benchmark report, even as it identified seven

Dr Reddy’s Laboratories is strategically shifting focus towards biosimilars and innovation. The company is increasing investment in biosimilars, anticipating significant growth within five years. Generics

Mumbai: A new study from the Tata Memorial Centre has highlighted that many modern cancer medicines, especially immunotherapy, are far too expensive for most people

The government mandated a blue line on antibiotic packaging to combat misuse. However, pharmaceutical companies argue this will disrupt operations and finances. They believe the

Oncology is a focus area in Medical Life Sciences for several reasons.Cancer is still one of the biggest health threats globally. It has many faces,

The new plant will feature zero liquid discharge (ZLD) technology and an advanced effluent treatment plant, designed to cut energy use by 70 per cent

As dengue surges globally, an Indian vaccine candidate has entered the final stage of testing, raising hopes for one of the world’s first single-dose shots

For many years, some countries have been called the “world’s pharmacy” because they produce large amounts of affordable medicines. Their focus has mainly been on

Virupaksha Organics Limited, a pharmaceutical company engaged in the manufacture of active pharmaceutical ingredients (APIs) and intermediates, has received the Securities and Exchange Board of

Warning of a “grave threat to public health”, the All India Organisation of Chemists and Druggists (AIOCD) has written to Prime Minister Narendra Modi, alleging